Department for Clinical Neurosciences and Preventive Medicine, Danube University Krems, Krems, Austria.
Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
Eur J Neurol. 2024 Nov;31(11):e16312. doi: 10.1111/ene.16312. Epub 2024 May 14.
One hundred years ago, an influenza pandemic swept across the globe that coincided with the development of a neurological condition, named "encephalitis lethargica" for the occurrence of its main symptom, the sudden onset of sleepiness that either developed into coma or gradually receded. Between 1917 and 1920, mortality of the flu was >20 million and of encephalitis lethargica approximately 1 million. For lessons to be learned from this pandemic, it makes sense to compare it with the COVID-19 pandemic, which occurred 100 years later. Biomedical progress had enabled testing, vaccinations, and drug therapies accompanied by public health measures such as social distancing, contact tracing, wearing face masks, and frequent hand washing. From todays' perspective, these public health measures are time honored but not sufficiently proven effective, especially when applied in the context of a vaccination strategy. Also, the protective effects of lockdowns of schools, universities, and other institutions and the restrictions on travel and personal visits to hospitals or old-age homes are not precisely known. Preparedness is still a demand for a future pandemic. Clinical trials should determine the comparative effectiveness of such public health measures, especially for their use as a combination strategy with vaccination and individual testing of asymptomatic individuals. It is important for neurologists to realize that during a pandemic the treatment possibilities for acute stroke and other neurological emergencies are reduced, which has previously led to an increase of mortality and suffering. To increase preparedness for a future pandemic, neurologists play an important role, as the case load of acute and chronic neurological patients will be higher as well as the needs for rehabilitation. Finally, new chronic forms of postviral disease will likely be added, as was the case for postencephalitic parkinsonism a century ago and now has occurred as long COVID.
一百年前,一场流感大流行席卷全球,与此同时,一种名为“昏睡性脑炎”的神经系统疾病也随之出现,其主要症状是突然发作的嗜睡,要么发展成昏迷,要么逐渐消退。在 1917 年至 1920 年间,流感的死亡率超过 2000 万,而昏睡性脑炎的死亡率约为 100 万。为了从这次大流行中吸取教训,将其与 100 年后发生的 COVID-19 大流行进行比较是有意义的。生物医学的进步使测试、疫苗接种和药物治疗成为可能,同时还采取了公共卫生措施,如保持社交距离、追踪接触者、戴口罩和经常洗手。从今天的角度来看,这些公共卫生措施是经过时间考验的,但还没有被充分证明是有效的,特别是在接种策略的背景下。此外,学校、大学和其他机构的封锁以及对旅行和个人探访医院或养老院的限制对保护的效果也不是很明确。为未来的大流行做好准备仍然是一项需求。临床试验应该确定这些公共卫生措施的相对有效性,特别是将其作为与疫苗接种和对无症状个体进行个体检测相结合的策略的使用。重要的是,神经科医生要意识到,在大流行期间,急性中风和其他神经急症的治疗可能性会降低,这以前导致死亡率和痛苦增加。为了增加对未来大流行的准备,神经科医生扮演着重要的角色,因为急性和慢性神经患者的病例量将会增加,同时对康复的需求也会增加。最后,可能会出现新的慢性病毒性疾病形式,就像一个世纪前的脑炎后帕金森病一样,现在已经出现了长新冠。